Skip to content

Chronic fatigue syndrome and homoeopathy

Individualized homoeopathic treatment with consideration of accessory circumstances of chronic fatigue syndrome: An open label, single arm, clinical trial - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/11/096760
Enrollment
74
Registered
2025-11-03
Start date
Unknown
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G933- Postviral fatigue syndrome

Interventions

Sponsors

Dr Shivangi Pandey
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Fatigue lasts for at least 6 months and is not relieved by rest. 2.Fatigue resulting in substantial reduction in previous occupational, educational, social and personal activities. 3.Presence of any other symptoms related with fatigue: muscle pain, headache, unrefreshing sleep, malaise after exertion, impaired memory, deterioration in the concentration level. 4.Scoring will be done using Likert scoring system, where minimum score possible would be 3 and a maximum of 33. 5.Patients with the age group from 18 to 60. 6.Individuals who can read and/or write English/Bengali/Hindi. 7.Individuals willing to participate in trial and give written consent for the same.

Exclusion criteria

Exclusion criteria: 1.Individuals who are currently on any other homoeopathic treatment or undergoing any kind of treatment for chronic fatigue from any system of medicine. 2.Individuals with any life threatening disease. 3.Pregnant or lactating mothers. 4.Patient with any Systemic Disorder, Major depressive disorder (psychotic features) or bipolar disorder. 5.Patient below 18 and above 60 years of age. 6.mmunocompromised individuals.

Design outcomes

Primary

MeasureTime frame
To detect pre- and post-treatment score using CHALDER FATIGUE SCALE in patients with chronic fatigue syndrome.Timepoint: At baseline and after 3 months of treatment.

Secondary

MeasureTime frame
1.To evaluate the changes in the quality of life with SF 12 scores. 2.To shortlist accessory circumstances in chronic fatigue syndrome 3.To shortlist most indicated medicines in chronic fatigue syndrome.Timepoint: At baseline & after 3 months of treatment.

Countries

India

Contacts

Public ContactProf (Dr) Rajat Chattopadhyay

The Calcutta Homoeopathic Medical College and Hospital

dr.rajatchatterjee@gmail.com9331041142

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026